Abstract:The digestive characteristics of mulberrin (Mul) in the oral-gastrointestinal tract and its inhibitory effects on Lachnospira bacterium along with associated metabolic regulation mechanisms were elucidated in the present study. In vitro simulated digestion models coupled with high-performance liquid chromatography (HPLC) were employed to quantitatively analyze the dynamic changes and digestive rates of Mul in gastrointestinal environments. Five mass concentration gradients of Mul were administered to Lachnospira bacterium to assess dose-dependent effects. Metabolites derived from Lachnospira bacterium biotransformation of Mul were collected at three timepoints and systematically analyzed using untargeted metabolomics. After 2 h in simulated gastric conditions, 71.50% of Mul was digested, while complete degradation (100%) was observed following 2 h in simulated intestinal environments; A significant dose-dependent inhibitory effect on Lachnospira bacterium was demonstrated,with an inhibition rate of 89.35% at the highest concentration (1000 μg·mL-1); Untargeted metabolomic analysis indicateddistinct metabolic profiles between Mul-treated and blank control (BC) groups, wherein Lachnospira bacterium dynamically converted Mul into characteristic metabolites including parvisoflavone B, kuwanon K, and morusinol. It was concluded that Mul exhibiteds gradient digestion in the oral-gastrointestinal system; its inhibitory efficacy correlateds positively with concentration; Mul modulateds lipid metabolic homeostasis by regulating Lachnospira bacterium abundance, inducing characteristic metabolite production, and significantly altering linoleic acid metabolism (P<0.0001), arachidonic acid metabolism (P<0.05), and caffeine metabolism pathways (P<0.05). This investigation provideds key mechanistic insights for developing flavonoid-based microbiota-targeted anti-obesity strategies.